Financhill
Buy
59

RGLS Quote, Financials, Valuation and Earnings

Last price:
$7.94
Seasonality move :
-22.76%
Day range:
$7.91 - $7.95
52-week range:
$0.83 - $8.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.96x
Volume:
819.4K
Avg. volume:
2.4M
1-year change:
250.89%
Market cap:
$549.7M
Revenue:
--
EPS (TTM):
-$0.73

Earnings Data

Next earnings date for RGLS
Aug 08
2025
Most recent earnings per share
-$0.15
Beat by $0.12
(May 8/2025)
Consensus Estimate
-$0.27
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RGLS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 -- -- -- -$0.18 --
05/08/2025 Q1 -- -- -$0.15 -$0.27 $0.12
03/13/2025 Q4 -- -- -$0.20 -$0.22 $0.02
11/07/2024 Q3 -- -- -$0.21 -$0.17 -$0.04
08/08/2024 Q2 -- -- -$0.17 -$0.16 -$0.01
05/09/2024 Q1 -- -- -$0.29 -$0.26 -$0.03
03/21/2024 Q4 -- -- -$0.39 -$0.39 --
11/09/2023 Q3 -- -- -$0.40 -$0.40 -$0.00
08/08/2023 Q2 -- -- -$0.37 -$0.41 $0.04
05/12/2023 Q1 -- -- -$0.42 -$0.44 $0.02
03/10/2023 Q4 -- -- -$0.40 -$0.51 $0.11
11/10/2022 Q3 -- -- -$0.50 -$0.49 -$0.01
08/11/2022 Q2 -- -- -$0.50 -$0.42 -$0.09
05/12/2022 Q1 -- -- -$0.46 -$0.55 $0.09
03/10/2022 Q4 -- -- -$0.70 -- --
11/10/2021 Q3 -- -- -$0.99 -- --
08/10/2021 Q2 -- -- -$0.78 -- --
05/13/2021 Q1 -- -- -$0.80 -- --
03/09/2021 Q4 -- -- -$0.30 -- --
09/30/2020 Q3 -- -- -$0.40 -- --
06/30/2020 Q2 -- -- -$2.30 -- --
03/31/2020 Q1 -- -- -$2.50 -- --
12/31/2019 Q4 -- -- -$2.30 -- --
09/30/2019 Q3 -- -- -$2.60 -- --
06/30/2019 Q2 -- -- -$3.00 -- --
03/31/2019 Q1 -- -- -$3.10 -- --
12/31/2018 Q4 -- -- -$9.80 -- --
11/07/2018 Q3 -- -- -$11.80 -- --
08/09/2018 Q2 -- -- -$15.90 -- --
05/10/2018 Q1 -- -- -$18.50 -- --
03/07/2018 Q4 -- -- -$16.80 -- --
11/07/2017 Q3 -- -- -$21.10 -- --
08/01/2017 Q2 -- -- -$49.20 -- --
05/04/2017 Q1 -- -- -$45.60 -- --
03/02/2017 Q4 -- -- -$45.60 -- --
11/01/2016 Q3 -- -- -$44.40 -- --
08/02/2016 Q2 -- -- -$48.00 -- --
05/02/2016 Q1 -- -- -$48.00 -- --
02/22/2016 Q4 -- -- -$16.80 -- --
11/05/2015 Q3 -- -- -$30.00 -- --
08/04/2015 Q2 -- -- -$49.20 -- --

Regulus Therapeutics Earnings Questions

  • How Much did Regulus Therapeutics Generate in Revenue Last Quarter?

    Regulus Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Regulus Therapeutics Beat Earnings Last Quarter?

    Regulus Therapeutics announced earnings per share of -$0.15 which represents a beat of analyst forecast a -$0.27 per share.

  • Is Regulus Therapeutics Profitable?

    Regulus Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Regulus Therapeutics EPS Next Year?

    Regulus Therapeutics's earnings are forecast to decrease from -$0.82 per share to -$0.87 per share next year representing a decrease of -4.47%.

  • When is Regulus Therapeutics's Earnings Date?

    Regulus Therapeutics's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Where Will Cameco Stock Be in 5 Years?
Where Will Cameco Stock Be in 5 Years?

Cameco (NYSE: CCJ) isn’t exactly the kind of stock you…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 47x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
82
SBET alert for May 31

SharpLink Gaming [SBET] is down 3.17% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Buy
56
SVT alert for May 31

Servotronics [SVT] is up 0.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock